Metastatic breast cancer : why are we here and where are we going?CROWN, John.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 13, pp 2-5, issn 1359-6349, 4 p.Conference Paper

A Personalized Approach to Cancer Treatment : How Biomarkers Can HelpDUFFY, Michael J; CROWN, John.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 11, pp 1770-1779, issn 0009-9147, 10 p.Article

Maximising outcomes in adjuvant breast cancerCROWN, John.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 21-24, issn 1359-6349, 4 p.Article

Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapyCROWN, John; PEGRAM, Mark.Breast cancer research and treatment. 2003, Vol 79, pp S11-S18, issn 0167-6806, SUP1Conference Paper

Truncated HER2: implications for HER2-targeted therapeuticZAGOZDZON, Radoslaw; GALLAGHER, William M; CROWN, John et al.Drug discovery today. 2011, Vol 16, Num 17-18, pp 810-816, issn 1359-6446, 7 p.Article

Case 3. Ulcerating cytomegalovirus bronchitis in a patient with relapsed non-Hodgkin's lymphomaOOI, Wei S; CROWN, John P.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 4022-4023, issn 0732-183X, 2 p.Article

The platinum agents: a role in breast cancer treatment?CROWN, John P.Seminars in oncology. 2001, Vol 28, Num 1, pp 28-37, issn 0093-7754, SUP3Article

Targeted therapy for triple-negative breast cancer: Where are we?DUFFY, Michael J; MCGOWAN, Patricia M; CROWN, John et al.International journal of cancer (Print). 2012, Vol 131, Num 11, pp 2471-2477, issn 0020-7136, 7 p.Article

Rapid and sensitive liquid chromatography-tandem mass spectrometry for the quantitation of epirubicin and identification of metabolites in biological samplesWALL, Rachel; MCMAHON, Gillian; CROWN, John et al.Talanta (Oxford). 2007, Vol 72, Num 1, pp 145-154, issn 0039-9140, 10 p.Article

Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancerFRIEL, Anne M; CORCORAN, Claire; CROWN, John et al.Breast cancer research and treatment. 2010, Vol 123, Num 3, pp 613-625, issn 0167-6806, 13 p.Article

Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancerDOWLING, Paul; CLARKE, Colin; CLYNES, Martin et al.International journal of cancer (Print). 2012, Vol 131, Num 4, pp 911-923, issn 0020-7136, 13 p.Article

Intracellular and Extracellular MicroRNAs in Breast CancerCORCORAN, Claire; FRIEL, Anne M; DUFFY, Michael J et al.Clinical chemistry (Baltimore, Md.). 2011, Vol 57, Num 1, pp 18-32, issn 0009-9147, 15 p.Article

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel : Breast International Group 02-98 Randomized TrialFRANCIS, Prudence; CROWN, John; GUTIERREZ, Jorge et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 2, pp 121-133, issn 0027-8874, 13 p.Article

Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer PatientsHURVITZ, Sara A; BETTING, David J; DAMARAJU, Sambasivarao et al.Clinical cancer research (Print). 2012, Vol 18, Num 12, pp 3478-3486, issn 1078-0432, 9 p.Article

MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesisGERMANO, Serena; KENNEDY, Susan; RANI, Sweta et al.International journal of cancer (Print). 2012, Vol 130, Num 9, pp 1991-2002, issn 0020-7136, 12 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell linesEUSTACE, Alex J; DOWLING, Paul; HENRY, Michael et al.Journal of proteomics (Print). 2011, Vol 74, Num 4, pp 490-501, issn 1874-3919, 12 p.Article

Alteration of Topoisomerase II―Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based ChemotherapyPRESS, Michael F; SAUTER, Guido; ROBERT, Nicholas et al.Journal of clinical oncology. 2011, Vol 29, Num 7, pp 859-867, issn 0732-183X, 9 p.Article

Doxorubicin followed by docetaxel versus docetaxel followed by Doxorubicin in the adjuvant treatment of node positive breast cancer : results of a feasibility studyCARDOSO, Fatima; FERREIRA, A. F; CROWN, John et al.Anticancer research. 2001, Vol 21, Num 1B, pp 789-795, issn 0250-7005Article

Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase InhibitorsRANI, Sweta; CORCORAN, Claire; GOGARTY, Martina et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3821-3833, issn 0008-5472, 13 p.Article

Adjuvant Trastuzumab in HER2-Positive Breast CancerSLAMON, Dennis; EIERMANN, Wolfgang; PINTER, Tamas et al.The New England journal of medicine. 2011, Vol 365, Num 14, pp 1273-1283, issn 0028-4793, 11 p.Article

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic RegimensVALERO, Vicente; FORBES, John; FUMOLEAU, Pierre et al.Journal of clinical oncology. 2011, Vol 29, Num 2, pp 149-156, issn 0732-183X, 8 p.Article

Prevalence and prognostic and predictive relevance of PRAME in breast cancerDOOLAN, Padraig; CLYNES, Martin; KENNEDY, Susan et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 359-365, issn 0167-6806, 7 p.Article

Caspase 3 in breast cancerO'DONOVAN, Norma; CROWN, John; STUNELL, Helen et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 738-742, issn 1078-0432, 5 p.Article

Priority-setting decisions for new cancer drugs : a qualitative case study. CommentaryMARTIN, Douglas K; PATER, Joseph L; SINGER, Peter A et al.Lancet (British edition). 2001, Vol 358, Num 9294, issn 0140-6736, 1660,1676-1681 [7 p.]Article